Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Clinical Trials > Double-Blind Randomized Controlled Trial of MiraLAX versus Placebo to Prevent Constipation Following Urogynecologic Surgery in Women Receiving Routine Docusate Sodium
Jumbo Large Regular Text:
Print
Clinical Trials

Double-Blind Randomized Controlled Trial of MiraLAX versus Placebo to Prevent Constipation Following Urogynecologic Surgery in Women Receiving Routine Docusate Sodium

Related Content

Health Articles

  • Understanding Clinical Trials: A participants' guide

In This Section

Related Clinical Trials

  • Gynecology
  • Women's Health

Share

Purpose: to determine if a small daily dose of an over- the-counter laxative will help improve bowel function in the week following pelvic surgery

Age range: Females 21 year of age and older who are planning to undergo pelvic surgery

Study activities:
-No extra study visits
-Complete questionnaires and bowel diaries
-Randomly assigned to received MiraLAX or placebo to be taken for 5 days after surgery
-Take a stool softener for 30 days after surgery

Study Duration: 6 weeks

Compensation: Up to $40

For more information, contact Grace Fulton at 919-401-1017.


(REF# Pro00035126)
Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Oct. 12, 2012
Published: Oct. 12, 2012
URL: http://www.dukehealth.org/clinicaltrials/20120920131329772